VIDEO
Cepheid and Max Foundation collaboration impacts CML patients around the globe
Our BCR-ABL test is playing a pivotal role in Cepheid’s vision of making molecular testing accessible to patients everywhere. In 2012, Cepheid partnered with The Max Foundation, an organization that channels humanitarian donations of life-saving oncology products to underserved populations in countries where those products are not locally available.
Through this collaboration of shared values, Cepheid offers compassion pricing of its GeneXpert IV instruments and Xpert BCR-ABL test for CML patients in specified low- and middle-income countries. Cepheid is also a proud sponsor of the Max Foundation initiative, My PCR, a patient driven program with the mission of educating all CML patients about the importance of monitoring their treatment with PCR testing.